Nutra Pharma Corp (NPHC) stock
NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $806.69KP/E –Yield –
Nutra Pharma gross margin
Gross margin is gross profit as a percentage of revenue.
Nutra Pharma's gross margin for the twelve months ending Jun 30, 2026 was 64.8%. For fiscal 2025 it was 76.3%, against 100.4% the year before. The highest annual figure on record is 192.9% in fiscal 2023.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 76.3% | −24.1 |
| FY2024 | Dec 31, 2024 | 100.4% | −92.5 |
| FY2023 | Dec 31, 2023 | 192.9% | +22.1 |
| FY2022 | Dec 31, 2022 | 170.8% | +162.1 |
| FY2021 | Dec 31, 2021 | 8.7% | −20.1 |
| FY2020 | Dec 31, 2020 | 28.7% | −4.5 |
| FY2019 | Dec 31, 2019 | 33.3% | +22.5 |
| FY2018 | Dec 31, 2018 | 10.8% | −67.0 |
| FY2017 | Dec 31, 2017 | 77.8% | +110.2 |
| FY2016 | Dec 31, 2016 | -32.5% | −109.9 |
| FY2015 | Dec 31, 2015 | 77.4% | −3.4 |
| FY2014 | Dec 31, 2014 | 80.8% | +20.0 |
| FY2013 | Dec 31, 2013 | 60.7% | +33.4 |
| FY2012 | Dec 31, 2012 | 27.4% | +478.5 |
| FY2011 | Dec 31, 2011 | -451.1% | −508.1 |
| FY2010 | Dec 31, 2010 | 56.9% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 94.7% | +19.6 |
| Q1 FY2026 | Mar 31, 2026 | 69.6% | −10.3 |
| Q4 FY2025 | Dec 31, 2025 | -41.3% | −147.0 |
| Q3 FY2025 | Sep 30, 2025 | 91.9% | −2.3 |
| Q2 FY2025 | Jun 30, 2025 | 75.0% | −31.0 |
| Q1 FY2025 | Mar 31, 2025 | 79.9% | −13.3 |
| Q4 FY2024 | Dec 31, 2024 | 105.8% | −93.6 |
| Q3 FY2024 | Sep 30, 2024 | 94.3% | −128.5 |
| Q2 FY2024 | Jun 30, 2024 | 106.1% | −55.5 |
| Q1 FY2024 | Mar 31, 2024 | 93.3% | −95.8 |
| Q4 FY2023 | Dec 31, 2023 | 199.3% | +17.6 |
| Q3 FY2023 | Sep 30, 2023 | 222.8% | −54.0 |
| Q2 FY2023 | Jun 30, 2023 | 161.5% | +57.5 |
| Q1 FY2023 | Mar 31, 2023 | 189.1% | +132.5 |
| Q4 FY2022 | Dec 31, 2022 | 181.7% | +331.7 |
| Q3 FY2022 | Sep 30, 2022 | 276.8% | +226.8 |
| Q2 FY2022 | Jun 30, 2022 | 104.0% | +33.6 |
| Q1 FY2022 | Mar 31, 2022 | 56.6% | −17.8 |
| Q4 FY2021 | Dec 31, 2021 | -150.1% | −85.8 |
| Q3 FY2021 | Sep 30, 2021 | 49.9% | −26.8 |
| Q2 FY2021 | Jun 30, 2021 | 70.4% | +29.5 |
| Q1 FY2021 | Mar 31, 2021 | 74.4% | +5.3 |
| Q4 FY2020 | Dec 31, 2020 | -64.2% | +237.7 |
| Q3 FY2020 | Sep 30, 2020 | 76.8% | −7.7 |
| Q2 FY2020 | Jun 30, 2020 | 40.9% | −22.1 |
| Q1 FY2020 | Mar 31, 2020 | 69.2% | +7.0 |
| Q4 FY2019 | Dec 31, 2019 | -301.9% | −180.4 |
| Q3 FY2019 | Sep 30, 2019 | 84.5% | +69.6 |
| Q2 FY2019 | Jun 30, 2019 | 63.1% | +19.5 |
| Q1 FY2019 | Mar 31, 2019 | 62.2% | −19.8 |
| Q4 FY2018 | Dec 31, 2018 | -121.5% | −210.0 |
| Q3 FY2018 | Sep 30, 2018 | 14.9% | −39.2 |
| Q2 FY2018 | Jun 30, 2018 | 43.6% | −21.5 |
| Q1 FY2018 | Mar 31, 2018 | 82.0% | +1.9 |
| Q4 FY2017 | Dec 31, 2017 | 88.5% | – |
| Q1 FY2017 | Mar 31, 2017 | 54.1% | – |
| Q2 FY2016 | Jun 30, 2016 | 65.1% | – |
| Q1 FY2016 | Mar 31, 2016 | 80.0% | – |
See a number that looks wrong?